Hyperhomocysteinemia in women with advanced breast cancer.
about
SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer.Plasma homocysteine and cysteine and risk of breast cancer in women.Elevated homocysteine level and folate deficiency associated with increased overall risk of carcinogenesis: meta-analysis of 83 case-control studies involving 35,758 individuals.Hyperhomocysteinemia and the role of B vitamins in cancer.Congenital thrombophilia and central venous catheter-related thrombosis in patients with cancer.Nutritional essentiality of sulfur in health and disease.Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective.Plasma Riboflavin and Vitamin B-6, but Not Homocysteine, Folate, or Vitamin B-12, Are Inversely Associated with Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition-Varese Cohort.The nitrative and oxidative stress in blood platelets isolated from breast cancer patients: the protectory action of aronia melanocarpa extract.Systemic chemotherapy interferes in homocysteine metabolism in breast cancer patients.The changes of blood platelet activation in breast cancer patients before surgery, after surgery, and in various phases of the chemotherapy.Changes in plasma thiol levels induced by different phases of treatment in breast cancer; the role of commercial extract from black chokeberry.Circulating tumor cell detection during chemotherapy in patients with breast cancer is not associated with plasma homocysteine levels.The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients.Plasma total homocysteine level in association with folate, pyridoxine, and cobalamin status among Iranian primary breast cancer patients.Haplotypes of the MTHFR gene are associated with an increased risk of breast cancer in a Han Chinese population in Gansu province.
P2860
Q33710175-E7811AA0-1D6E-4683-BDF1-49C7E6C98E3DQ33733182-B3269898-630E-4C00-A482-D461138BC9E5Q35620594-0E5EA676-5A12-4FA6-A26E-19538E409D90Q36177626-264951C7-50CD-4C75-B9FB-9A8F9C0F2517Q37763366-2963AF72-CBC3-4BBD-B715-CB4A7AE38ED9Q38118338-25E41559-3EFE-4DE0-B90E-DDFCA30A0B4AQ39112249-E7C1AA6F-6D0C-4CA0-B915-055DD9F50117Q40778854-F5D76377-8FAF-43C7-BAFB-606F5515C01AQ42972737-83F2EC79-6489-4A11-B80A-3BC859A4851FQ44591661-B0FC7971-24CB-4197-A484-96ACC852CCE7Q47293911-2A6408FF-7D36-4354-85D8-145D23B5E3C5Q50914265-07232E55-DED8-48B4-8E11-1D3EF9501FEBQ50981135-B68605E9-AFE5-474D-B8ED-328009CC4169Q51036455-9393B238-9EE9-4544-B6B5-87C762D33BC3Q51316787-2971CB47-EA83-427C-A0FA-F0BDD5358ACBQ53092434-EB469EFC-34C3-447B-BAA4-57D375904038
P2860
Hyperhomocysteinemia in women with advanced breast cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Hyperhomocysteinemia in women with advanced breast cancer.
@en
Hyperhomocysteinemia in women with advanced breast cancer.
@nl
type
label
Hyperhomocysteinemia in women with advanced breast cancer.
@en
Hyperhomocysteinemia in women with advanced breast cancer.
@nl
prefLabel
Hyperhomocysteinemia in women with advanced breast cancer.
@en
Hyperhomocysteinemia in women with advanced breast cancer.
@nl
P2093
P2860
P1476
Hyperhomocysteinemia in women with advanced breast cancer.
@en
P2093
Burcombe RJ
Thompson D
P2860
P304
P356
10.1111/J.1751-553X.2007.00907.X
P577
2007-12-01T00:00:00Z